WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010118878) MUSCLE FUNCTION ENHANCING PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/118878    International Application No.:    PCT/EP2010/002343
Publication Date: 21.10.2010 International Filing Date: 16.04.2010
IPC:
A61K 38/17 (2006.01), C07K 14/47 (2006.01)
Applicants: UNIVERSITÄTSKLINIKUM HEIDELBERG [DE/DE]; Im Neuenheimer FeId 672 69120 Heidelberg (DE) (For All Designated States Except US).
MOST, Patrick [DE/DE]; (DE) (For US Only).
VOELKERS, Mirko [DE/DE]; (DE) (For US Only).
KATUS, Hugo [DE/DE]; (DE) (For US Only).
REMPPIS, Andrew [DE/DE]; (DE) (For US Only)
Inventors: MOST, Patrick; (DE).
VOELKERS, Mirko; (DE).
KATUS, Hugo; (DE).
REMPPIS, Andrew; (DE)
Agent: ZWICKER, Jörk; Patent und Rechtsanwaltskanzlei Geibelstrasse 6 81679 Mϋnchen (DE)
Priority Data:
61/169,962  16.04.2009 US
Title (EN) MUSCLE FUNCTION ENHANCING PEPTIDE
(FR) PEPTIDE AMÉLIORANT LA FONCTION MUSCULAIRE
Abstract: front page image
(EN)The present invention relates to a peptide comprising a muscle function enhancing amino acid sequence which is derived from the S100 calcium binding protein family. Furthermore, the present invention provides said peptide for medical use, in particular, for treating or preventing disorders associated with muscular malfunction, such as skeletal muscle or cardiac muscle disorders. The present invention also provides a pharmaceutical composition comprising said peptide and a method for treating or preventing disorders associated with muscular malfunction using said peptide or said pharmaceutical composition.
(FR)La présente invention concerne un peptide comprenant une séquence d'acides aminés, qui est dérivée de la famille de protéine S100 se liant au calcium, et qui renforce la fonction musculaire. L'invention concerne en outre l'utilisation médicale de ce peptide, en particulier pour le traitement ou la prévention de troubles associés à des dysfonctions musculaires telles que des troubles des muscles squelettiques ou du myocarde. L'invention concerne également une composition pharmaceutique comprenant ce peptide et un procédé mettant en œuvre ce peptide ou cette composition pharmaceutique pour traiter ou prévenir des troubles associés à des dysfonctions musculaires.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)